DATE: October 21st, 2024
LOCATION: New Orleans, Louisiana (The Westin New Orleans in New Orleans, CA Map)
Registration: Click here to register
Target Audience: ESIs who focus on preclinical or clinical HIV vaccine research and are within ten (10) years of completing their terminal research degree (PhD, MD, DVM), medical residency, or equivalent.
PROGRAM DETAILS: Click here to view the 2023 conference program. 2024 Program Coming Soon!!
This one-day conference is intended for ESIs who focus on translational HIV research in non-human primates (NHPs), or clinical HIV and TB research, and are within 10 years of completing their terminal research degree (PhD, MD, DVM), medical residency, or equivalent. Investigators will participate in career mentoring and networking designed for ESI working in translational HIV research. Past attendees have stated that the Conference has increased their skills and knowledge for career development and provided them with a venue to form new collaborations.
Attendees at this conference should be Early Stage Investigators (ESIs) actively engaged in translational, clinical, or pre-clinical HIV or TB vaccine research. An ESI is defined as a person within ten (10) years of completing their terminal research degree (PhD, MD, DVM), medical residency, or equivalent and has not received an NIH R01 grant. There is no fee to attend the ESI conference. Attendees will also be invited to an NIH-sponsored pediatric-oriented meeting on Tuesday, October 22, and the NHP AIDS Symposium will commence on the same day. For more information and to register for the NHP AIDS Symposium, please visit the following site: https://tnprc.tulane.edu/nhp-aids